ArticleAntimicrobial agents and chemotherapy2014

Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori.

Paul S Hoffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.